Clinical Data

Diabetes obesity weight loss

Biotech

Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test

Eli Lilly is rounding out its pitch for retatrutide with new data looking at blood sugar reductions and weight loss in patients with Type 2 diabetes.

Fraiser Kansteiner Mar 19, 2026 6:45am

Small sprouting plant starting to grow

Aspen's Parkinson's cell therapy data plant seeds for ph. 3

Mar 18, 2026 9:00am

gold arrow pointing upward forward

Pfizer's hotly tipped breast cancer prospect records phase 2 win

Mar 17, 2026 8:40am

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

BridgeBio's muscle weakness data impress ahead of FDA filing

Mar 12, 2026 10:30am

step up climb ladder sky hang on rung

Regenxbio gene therapy passes interim test as pivotal data loom

Mar 12, 2026 5:49am

weight loss scale weigh measure tape obesity overweight

Ascletis eyes quarterly GLP-1 dosing following phase 2 readout

Mar 10, 2026 8:20am